BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 8247035)

  • 21. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
    Flowers M; Sherker A; Sinclair SB; Greig PD; Cameron R; Phillips MJ; Blendis L; Chung SW; Levy GA
    Transplantation; 1994 Jul; 58(2):183-92. PubMed ID: 8042236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of viral recurrence following liver transplantation for post-hepatitis B and B-delta cirrhosis].
    Mentha G; Giostra E; Perrin L; Widmann JJ; Stelling MJ; Easton J; Morel P; Huber O; Le Coultre C; Bühler L
    Schweiz Med Wochenschr; 1994 Apr; 124(15):637-41. PubMed ID: 8191267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Lu MQ; Cai CJ; Zhao H; Yang Y; Chen GH
    Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):742-4. PubMed ID: 16836920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma.
    Wong PY; McPeake JR; Portmann B; Tan KC; Naoumov NV; Williams R
    Am J Gastroenterol; 1995 Jan; 90(1):29-34. PubMed ID: 7801944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
    Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients.
    Samuel D; Bismuth A; Mathieu D; Arulnaden JL; Reynes M; Benhamou JP; Brechot C; Bismuth H
    Lancet; 1991 Apr; 337(8745):813-5. PubMed ID: 1672913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control.
    Harpaz R; Von Seidlein L; Averhoff FM; Tormey MP; Sinha SD; Kotsopoulou K; Lambert SB; Robertson BH; Cherry JD; Shapiro CN
    N Engl J Med; 1996 Feb; 334(9):549-54. PubMed ID: 8569821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis.
    Roche B; Feray C; Gigou M; Roque-Afonso AM; Arulnaden JL; Delvart V; Dussaix E; Guettier C; Bismuth H; Samuel D
    Hepatology; 2003 Jul; 38(1):86-95. PubMed ID: 12829990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study of the efficacy and safety of using hepatitis B surface antigen-positive donors for liver transplantation].
    Ju WQ; He XS; Wang DP; Deng RH; Wu LW; Guo ZY; Zhu XF; Huang JF
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):14-6. PubMed ID: 22464699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence. The European Cooperative Study Group on Liver Cancer and Transplantation.
    Mazzaferro V; Regalia E; Montalto F; Pulvirenti A; Brunetto MR; Bonino F; Lerut J; Gennari L
    Liver; 1996 Apr; 16(2):117-22. PubMed ID: 8740845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation in delta virus infection.
    Roche B; Samuel D
    Semin Liver Dis; 2012 Aug; 32(3):245-55. PubMed ID: 22932973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.
    Loggi E; Micco L; Ercolani G; Cucchetti A; Bihl FK; Grazi GL; Gitto S; Bontadini A; Bernardi M; Grossi P; Costa AN; Pinna AD; Brander C; Andreone P
    J Hepatol; 2012 Mar; 56(3):579-85. PubMed ID: 22027583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis.
    Lenci I; Marcuccilli F; Tisone G; Di Paolo D; Tariciotti L; Ciotti M; Guenci T; Perno CF; Angelico M
    Dig Liver Dis; 2010 Aug; 42(8):578-84. PubMed ID: 20097143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression.
    Gish RG; Keeffe EB; Lim J; Brooks LJ; Esquivel CO
    J Hepatol; 1995 Mar; 22(3):257-62. PubMed ID: 7608474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.